Aummune

Aummune
Develops a platform for individual drug customization using aptamers for cancer treatment.
About
What does Aummune do?
Aummune is a clinical-stage company developing a novel, individualized immunotherapy for solid tumors. Their proprietary platform utilizes an efficacy-driven selection process to create patient-specific tri-functional oligonucleotide drugs that induce cancer cell death and activate immune responses. This approach aims to provide a new class of therapy for a broad spectrum of cancer indications.
What is Aummune's revenue?
StartupHub estimates Aummune's annual revenue at $1.0M (range $572K to $1.6M, 64% confidence), based on comparable companies in the sector.
What is Aummune's valuation?
StartupHub estimates Aummune's effective valuation at $39.8M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Aummune raised?
Aummune has raised a total of $10M in funding. The most recent round on record is Series A.
Where is Aummune headquartered?
Aummune is headquartered in San Diego, United States.
When was Aummune founded?
Aummune was founded in 2017.
What industry does Aummune operate in?
Aummune operates in Life Sciences, Cancer, Therapeutics, Biotech, Personalized Treatment, Drug Discovery.
How many employees does Aummune have?
Aummune has approximately 6 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.